ProShare Advisors’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Sell |
|
|||||
|
2025
Q1 | $247K | Sell |
|
|||||
|
2024
Q4 | $679K | Buy |
|
|||||
|
2024
Q3 | $618K | Buy |
|
|||||
|
2024
Q2 | $393K | Sell |
|
|||||
|
2024
Q1 | $922K | Buy |
|
|||||
|
2023
Q4 | $442K | Buy |
|
|||||
|
2023
Q3 | $209K | Buy |
|
|||||
|
2023
Q2 | $293K | Buy |
|
|||||
|
2023
Q1 | $203K | Buy |
|
|||||
|
2022
Q4 | $207K | Buy |
|
|||||
|
2022
Q3 | $287K | Buy |
|
|||||
|
2022
Q2 | $322K | Buy |
|
|||||
|
2022
Q1 | $270K | Sell |
|
|||||
|
2021
Q4 | $422K | Sell |
|
|||||
|
2021
Q3 | $817K | Buy |
|
|||||
|
2021
Q2 | $715K | Buy |
|
|||||
|
2021
Q1 | $644K | Sell |
|
|||||
|
2020
Q4 | $1.05M | Sell |
|
|||||
|
2020
Q3 | $777K | Buy |
|
|||||
|
2020
Q2 | $631K | Sell |
|
|||||
|
2020
Q1 | $725K | Sell |
|
|||||
|
2019
Q4 | $1.2M | Sell |
|
|||||
|
2019
Q3 | $848K | Sell |
|
|||||
|
2019
Q2 | $1.16M | Sell |
|
|||||
|
2019
Q1 | $508K | Buy |
|
|||||
|
2018
Q4 | $468K | Buy |
|
|||||
|
2018
Q3 | $552K | Buy |
|
|||||
|
2018
Q2 | $621K | Sell |
|
|||||
|
2018
Q1 | $844K | Buy |
|
|||||
|
2017
Q4 | $386K | Buy |
|
|||||
|
2017
Q3 | $302K | Buy |
|
|||||
|
2017
Q2 | $270K | Sell |
|
|||||
|
2017
Q1 | $296K | Sell |
|
|||||
|
2016
Q4 | $348K | Buy |
|
|||||
|
2016
Q3 | $347K | Buy |
|
|||||
|
2016
Q2 | $338K | Buy |
|
|||||
|
2016
Q1 | $207K | Sell |
|
|||||
|
2015
Q4 | $348K | Buy |
|